Neurosense Therapeutics Ltd banner
N

Neurosense Therapeutics Ltd
NASDAQ:NRSN

Watchlist Manager
Neurosense Therapeutics Ltd
NASDAQ:NRSN
Watchlist
Price: 0.8594 USD 1.11% Market Closed
Market Cap: $25.5m

Intrinsic Value

NRSN doesn't have a meaningful market cap.

The intrinsic value of one NRSN stock under the Base Case scenario is 1.0301 USD. Compared to the current market price of 0.8594 USD, Neurosense Therapeutics Ltd is Undervalued by 17%.

NRSN Intrinsic Value
1.0301 USD
Undervaluation 17%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Neurosense Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about NRSN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NRSN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Neurosense Therapeutics Ltd.

Explain Valuation
Alternatives to NRSN

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Neurosense Therapeutics Ltd

Wall St
Price Targets

Dividends

Neurosense Therapeutics Ltd
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one NRSN stock?

The intrinsic value of one NRSN stock under the Base Case scenario is 1.0301 USD.

Is NRSN stock undervalued or overvalued?

Compared to the current market price of 0.8594 USD, Neurosense Therapeutics Ltd is Undervalued by 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett